{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T01:38:35Z","timestamp":1792460315577,"version":"4.5.0"},"reference-count":108,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2022,5,24]],"date-time":"2022-05-24T00:00:00Z","timestamp":1653350400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100003130","name":"Fonds Wetenschappelijk Onderzoek","doi-asserted-by":"publisher","award":["1S56820N"],"award-info":[{"award-number":["1S56820N"]}],"id":[{"id":"10.13039\/501100003130","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003130","name":"Fonds Wetenschappelijk Onderzoek","doi-asserted-by":"publisher","award":["1S84418N"],"award-info":[{"award-number":["1S84418N"]}],"id":[{"id":"10.13039\/501100003130","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004040","name":"KU Leuven","doi-asserted-by":"publisher","award":["C32\/18\/067"],"award-info":[{"award-number":["C32\/18\/067"]}],"id":[{"id":"10.13039\/501100004040","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100015661","name":"UCB Pharma","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100015661","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Mol. Neurosci."],"abstract":"<jats:p>Synaptic vesicle glycoprotein 2A (SV2A) regulates action potential-dependent neurotransmitter release and is commonly known as the primary binding site of an approved anti-epileptic drug, levetiracetam. Although several rodent knockout models have demonstrated the importance of SV2A for functional neurotransmission, its precise physiological function and role in epilepsy pathophysiology remains to be elucidated. Here, we present a novel <jats:italic>sv2a<\/jats:italic> knockout model in zebrafish, a vertebrate with complementary advantages to rodents. We demonstrated that 6 days post fertilization homozygous <jats:italic>sv2a<jats:sup>\u2013\/\u2013<\/jats:sup><\/jats:italic> mutant zebrafish larvae, but not <jats:italic>sv2a<\/jats:italic><jats:sup>+\/\u2013<\/jats:sup> and <jats:italic>sv2a<jats:sup>+\/+<\/jats:sup><\/jats:italic> larvae, displayed locomotor hyperactivity and spontaneous epileptiform discharges, however, no major brain malformations could be observed. A partial rescue of this epileptiform brain activity could be observed after treatment with two commonly used anti-epileptic drugs, valproic acid and, surprisingly, levetiracetam. This observation indicated that additional targets, besides Sv2a, maybe are involved in the protective effects of levetiracetam against epileptic seizures. Furthermore, a transcriptome analysis provided insights into the neuropathological processes underlying the observed epileptic phenotype. While gene expression profiling revealed only one differentially expressed gene (DEG) between wildtype and <jats:italic>sv2a<\/jats:italic><jats:sup>+\/\u2013<\/jats:sup> larvae, there were 4386 and 3535 DEGs between wildtype and <jats:italic>sv2a<jats:sup>\u2013\/\u2013<\/jats:sup><\/jats:italic>, and <jats:italic>sv2a<\/jats:italic><jats:sup>+\/\u2013<\/jats:sup> and <jats:italic>sv2a<jats:sup>\u2013\/\u2013<\/jats:sup><\/jats:italic> larvae, respectively. Pathway and gene ontology (GO) enrichment analysis between wildtype and <jats:italic>sv2a<jats:sup>\u2013\/\u2013<\/jats:sup><\/jats:italic> larvae revealed several pathways and GO terms enriched amongst up- and down-regulated genes, including MAPK signaling, synaptic vesicle cycle, and extracellular matrix organization, all known to be involved in epileptogenesis and epilepsy. Importantly, we used the Connectivity map database to identify compounds with opposing gene signatures compared to the one observed in <jats:italic>sv2a<jats:sup>\u2013\/\u2013<\/jats:sup><\/jats:italic> larvae, to finally rescue the epileptic phenotype. Two out of three selected compounds rescued electrographic discharges in <jats:italic>sv2a<jats:sup>\u2013\/\u2013<\/jats:sup><\/jats:italic> larvae, while negative controls did not. Taken together, our results demonstrate that <jats:italic>sv2a<\/jats:italic> deficiency leads to increased seizure vulnerability and provide valuable insight into the functional importance of <jats:italic>sv2a<\/jats:italic> in the brain in general. Furthermore, we provided evidence that the concept of connectivity mapping represents an attractive and powerful approach in the discovery of novel compounds against epilepsy.<\/jats:p>","DOI":"10.3389\/fnmol.2022.881933","type":"journal-article","created":{"date-parts":[[2022,5,24]],"date-time":"2022-05-24T16:25:19Z","timestamp":1653409519000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":10,"title":["Connectivity Mapping Using a Novel sv2a Loss-of-Function Zebrafish Epilepsy Model as a Powerful Strategy for Anti-epileptic Drug Discovery"],"prefix":"10.3389","volume":"15","author":[{"given":"Yifan","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lise","family":"Heylen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mich\u00e8le","family":"Partoens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James D.","family":"Mills","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rafal M.","family":"Kaminski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrice","family":"Godard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michel","family":"Gillard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter A. M.","family":"de Witte","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aleksandra","family":"Siekierska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2022,5,24]]},"reference":[{"key":"B1","doi-asserted-by":"crossref","first-page":"507","DOI":"10.2147\/NDT.S2937","article-title":"Levetiracetam in the treatment of epilepsy.","volume":"4","author":"Abou-Khalil","year":"2008","journal-title":"Neuropsychiatr. Dis. Treat."},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1016\/j.lfs.2020.118826","article-title":"Revisiting the role of neurotransmitters in epilepsy: an updated review.","volume":"265","author":"Akyuz","year":"2021","journal-title":"Life Sci."},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1016\/j.lfs.2021.119923","article-title":"Levetiracetam promoted rat embryonic neurogenesis via NMDA receptor-mediated mechanism in vitro.","volume":"284","author":"Alavi","year":"2021","journal-title":"Life Sci."},{"key":"B4","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1038\/75556","article-title":"Gene ontology: tool for the unification of biology. The gene ontology consortium.","volume":"25","author":"Ashburner","year":"2000","journal-title":"Nat. Genet."},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms3410","article-title":"Drug screening in Scn1a zebrafish mutant identifies clemizole as a potential Dravet syndrome treatment.","volume":"4","author":"Baraban","year":"2013","journal-title":"Nat. Commun."},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.3389\/fnmol.2017.00148","article-title":"Puzzling out synaptic vesicle 2 family members functions.","volume":"10","author":"Bartholome","year":"2017","journal-title":"Front. Mol. Neurosci."},{"key":"B7","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1113\/jphysiol.1989.sp017762","article-title":"Giant synaptic potentials in immature rat CA3 hippocampal neurones.","volume":"416","author":"Ben-Ari","year":"1989","journal-title":"J. Physiol."},{"key":"B8","doi-asserted-by":"publisher","first-page":"1215","DOI":"10.1152\/physrev.00017.2006","article-title":"GABA: a pioneer transmitter that excites immature neurons and generates primitive oscillations.","volume":"87","author":"Ben-Ari","year":"2007","journal-title":"Physiol. Rev."},{"key":"B9","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1002\/acn3.703","article-title":"Drug repositioning in epilepsy reveals novel antiseizure candidates.","volume":"6","author":"Brueggeman","year":"2019","journal-title":"Ann. Clin. Transl. Neurol."},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1016\/j.ebr.2020.100425","article-title":"A de novo heterozygous rare variant in SV2A causes epilepsy and levetiracetam-induced drug-resistant status epilepticus.","volume":"15","author":"Calame","year":"2021","journal-title":"Epilepsy Behav. Rep."},{"key":"B11","doi-asserted-by":"publisher","first-page":"654","DOI":"10.1111\/j.1528-1167.2006.00973.x","article-title":"Modulation of AMPA receptors in cultured cortical neurons induced by the antiepileptic drug levetiracetam.","volume":"48","author":"Carunchio","year":"2007","journal-title":"Epilepsia"},{"key":"B12","doi-asserted-by":"publisher","first-page":"883","DOI":"10.1523\/jneurosci.4521-08.2009","article-title":"SV2 renders primed synaptic vesicles competent for Ca2+ -induced exocytosis.","volume":"29","author":"Chang","year":"2009","journal-title":"J. Neurosci."},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2105-14-128","article-title":"Enrichr: interactive and collaborative HTML5 gene list enrichment analysis tool.","volume":"14","author":"Chen","year":"2013","journal-title":"BMC Bioinformat."},{"key":"B14","doi-asserted-by":"publisher","first-page":"5546","DOI":"10.2174\/1381612823666171024130001","article-title":"Role of Histone Deacetylases (HDACs) in epilepsy and epileptogenesis.","volume":"23","author":"Citraro","year":"2017","journal-title":"Curr. Pharm. Des."},{"key":"B15","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1016\/B978-0-12-804066-9.00026-2","article-title":"Chapter 26 - zebrafish models of epilepsy and epileptic seizures A2 - Pitk\u00e4nen, Asla","author":"Copmans","year":"2017","journal-title":"Models of Seizures and Epilepsy"},{"key":"B16","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1586\/ern.10.5","article-title":"Levetiracetam: a comprehensive review.","volume":"10","author":"Crepeau","year":"2010","journal-title":"Expert Rev. Neurother."},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2202-14-87","article-title":"Expression of SV2 isoforms during rodent brain development.","volume":"14","author":"Cr\u00e8vec\u0153ur","year":"2013","journal-title":"BMC Neurosci."},{"key":"B18","doi-asserted-by":"publisher","first-page":"15268","DOI":"10.1073\/pnas.96.26.15268","article-title":"Abnormal neurotransmission in mice lacking synaptic vesicle protein 2A (SV2A).","volume":"96","author":"Crowder","year":"1999","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"B19","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1111\/j.1527-3458.2007.00004.x","article-title":"Levetiracetam: the profile of a novel anticonvulsant drug-part I: preclinical data.","volume":"13","author":"De Smedt","year":"2007","journal-title":"CNS Drug Rev."},{"key":"B20","doi-asserted-by":"publisher","first-page":"179","DOI":"10.4103\/ijmr.IJMR_1249_14","article-title":"Synaptic roles of cyclin-dependent kinase 5 & its implications in epilepsy.","volume":"145","author":"Dixit","year":"2017","journal-title":"Indian J. Med. Res."},{"key":"B21","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1093\/bioinformatics\/bts635","article-title":"STAR: ultrafast universal RNA-seq aligner.","volume":"29","author":"Dobin","year":"2013","journal-title":"Bioinformatics"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0026932","article-title":"Epilepsy caused by an abnormal alternative splicing with dosage effect of the SV2A gene in a chicken model.","volume":"6","author":"Douaud","year":"2011","journal-title":"PLoS One"},{"key":"B23","doi-asserted-by":"publisher","first-page":"7686","DOI":"10.1073\/pnas.92.17.7686","article-title":"A synthetic inhibitor of the mitogen-activated protein kinase cascade.","volume":"92","author":"Dudley","year":"1995","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"B24","doi-asserted-by":"publisher","first-page":"1184","DOI":"10.1038\/nprot.2009.97","article-title":"Mapping identifiers for the integration of genomic datasets with the R\/Bioconductor package biomaRt.","volume":"4","author":"Durinck","year":"2009","journal-title":"Nat. Protoc."},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuropharm.2019.107735","article-title":"Biomarkers for epileptogenesis and its treatment.","volume":"167","author":"Engel","year":"2020","journal-title":"Neuropharmacology"},{"key":"B26","doi-asserted-by":"publisher","first-page":"796","DOI":"10.1046\/j.1528-1157.2001.10401.x","article-title":"A proposed diagnostic scheme for people with epileptic seizures and with epilepsy: report of the ILAE task force on classification and terminology.","volume":"42","author":"Engel","year":"2001","journal-title":"Epilepsia"},{"key":"B27","doi-asserted-by":"publisher","first-page":"737","DOI":"10.1111\/j.0013-9580.2004.00104.x","article-title":"The activity of antiepileptic drugs as histone deacetylase inhibitors.","volume":"45","author":"Eyal","year":"2004","journal-title":"Epilepsia"},{"key":"B28","doi-asserted-by":"publisher","first-page":"354","DOI":"10.1007\/s12031-009-9288-2","article-title":"Down-regulation synaptic vesicle protein 2A in the anterior temporal neocortex of patients with intractable epilepsy.","volume":"39","author":"Feng","year":"2009","journal-title":"J. Mol. Neurosci."},{"key":"B29","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/j.pharmthera.2016.03.009","article-title":"Advancements in zebrafish applications for 21st century toxicology.","volume":"161","author":"Garcia","year":"2016","journal-title":"Pharmacol. Ther."},{"key":"B30","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1016\/j.ejphar.2006.02.022","article-title":"Binding characteristics of levetiracetam to synaptic vesicle protein 2A (SV2A) in human brain and in CHO cells expressing the human recombinant protein.","volume":"536","author":"Gillard","year":"2006","journal-title":"Eur. J. Pharmacol."},{"key":"B31","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1016\/j.ejphar.2011.04.064","article-title":"Binding characteristics of brivaracetam, a selective, high affinity SV2A ligand in rat, mouse and human brain: relationship to anti-convulsant properties.","volume":"664","author":"Gillard","year":"2011","journal-title":"Eur. J. Pharmacol."},{"key":"B32","doi-asserted-by":"publisher","first-page":"11083","DOI":"10.1523\/jneurosci.2766-06.2006","article-title":"Potential new antiepileptogenic targets indicated by microarray analysis in a rat model for temporal lobe epilepsy.","volume":"26","author":"Gorter","year":"2006","journal-title":"J. Neurosci."},{"key":"B33","doi-asserted-by":"publisher","first-page":"1429","DOI":"10.1182\/blood.v98.5.1429","article-title":"Lipopolysaccharide activation of the MEK-ERK1\/2 pathway in human monocytic cells mediates tissue factor and tumor necrosis factor alpha expression by inducing Elk-1 phosphorylation and Egr-1 expression.","volume":"98","author":"Guha","year":"2001","journal-title":"Blood"},{"key":"B34","author":"Hannon","year":"2010","journal-title":"Fastx-toolkit."},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.3389\/fnmol.2021.753936","article-title":"Pericardial injection of kainic acid induces a chronic epileptic state in larval Zebrafish.","volume":"14","author":"Heylen","year":"2021","journal-title":"Front. Mol. Neurosci."},{"key":"B36","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1242\/dmm.002139","article-title":"Zebrafish as a model for studying genetic aspects of epilepsy.","volume":"3","author":"Hortopan","year":"2010","journal-title":"Dis. Model. Mech."},{"key":"B37","doi-asserted-by":"publisher","first-page":"1489","DOI":"10.1096\/fj.09-145292","article-title":"Identification of novel hair-growth inducers by means of connectivity mapping.","volume":"24","author":"Ishimatsu-Tsuji","year":"2010","journal-title":"FASEB J."},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.12688\/f1000research.4536.1","article-title":"Enrichment Map - a Cytoscape app to visualize and explore OMICs pathway enrichment results.","volume":"3","author":"Isserlin","year":"2014","journal-title":"F1000Res"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.1016\/j.neulet.2019.134363","article-title":"Suppressive effects of levetiracetam on neuroinflammation and phagocytic microglia: a comparative study of levetiracetam, valproate and carbamazepine.","volume":"708","author":"Itoh","year":"2019","journal-title":"Neurosci. Lett."},{"key":"B40","doi-asserted-by":"publisher","first-page":"1003","DOI":"10.1016\/s0896-6273(00)81046-6","article-title":"SV2A and SV2B function as redundant Ca2+ regulators in neurotransmitter release.","volume":"24","author":"Janz","year":"1999","journal-title":"Neuron"},{"key":"B41","doi-asserted-by":"publisher","first-page":"1729","DOI":"10.1111\/j.1528-1167.2009.02089.x","article-title":"Proepileptic phenotype of SV2A-deficient mice is associated with reduced anticonvulsant efficacy of levetiracetam.","volume":"50","author":"Kaminski","year":"2009","journal-title":"Epilepsia"},{"key":"B42","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1093\/nar\/28.1.27","article-title":"KEGG: kyoto encyclopedia of genes and genomes.","volume":"28","author":"Kanehisa","year":"2000","journal-title":"Nucleic Acids Res."},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2019.07.024","article-title":"Interplay between a mental disorder risk gene and developmental polarity switch of GABA action leads to excitation-inhibition imbalance.","volume":"28","author":"Kang","year":"2019","journal-title":"Cell Rep."},{"key":"B44","doi-asserted-by":"publisher","first-page":"538","DOI":"10.1111\/epi.13340","article-title":"Brivaracetam: rationale for discovery and preclinical profile of a selective SV2A ligand for epilepsy treatment.","volume":"57","author":"Klitgaard","year":"2016","journal-title":"Epilepsia"},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2021.609908","article-title":"The synaptic vesicle protein 2A interacts with key pathogenic factors in Alzheimer\u2019s disease: implications for treatment.","volume":"9","author":"Kong","year":"2021","journal-title":"Front. Cell Dev. Biol."},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0193849","article-title":"Comprehensive analysis of T cell leukemia signals reveals heterogeneity in the PI3 kinase-Akt pathway and limitations of PI3 kinase inhibitors as monotherapy.","volume":"13","author":"Ksionda","year":"2018","journal-title":"PLoS One"},{"key":"B47","doi-asserted-by":"publisher","first-page":"1929","DOI":"10.1126\/science.1132939","article-title":"The Connectivity Map: using gene-expression signatures to connect small molecules, genes, and disease.","volume":"313","author":"Lamb","year":"2006","journal-title":"Science"},{"key":"B48","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1016\/j.bbr.2008.11.005","article-title":"Behavioural phenotyping reveals anxiety-like features of SV2A deficient mice.","volume":"198","author":"Lamberty","year":"2009","journal-title":"Behav. Brain Res."},{"key":"B49","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1038\/nmeth.1923","article-title":"Fast gapped-read alignment with Bowtie 2.","volume":"9","author":"Langmead","year":"2012","journal-title":"Nat. Methods"},{"key":"B50","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0116589","article-title":"Exploring the interaction of SV2A with racetams using homology modelling, molecular dynamics and site-directed mutagenesis.","volume":"10","author":"Lee","year":"2015","journal-title":"PLoS One"},{"key":"B51","doi-asserted-by":"publisher","DOI":"10.1016\/j.yebeh.2019.106542","article-title":"Glia and extracellular matrix molecules: What are their importance for the electrographic and MRI changes in the epileptogenic zone?","volume":"121","author":"Leite","year":"2021","journal-title":"Epilepsy Behav."},{"key":"B52","doi-asserted-by":"publisher","first-page":"2078","DOI":"10.1093\/bioinformatics\/btp352","article-title":"The sequence alignment\/map format and SAMtools.","volume":"25","author":"Li","year":"2009","journal-title":"Bioinformatics"},{"key":"B53","doi-asserted-by":"publisher","first-page":"7417","DOI":"10.1111\/jcmm.15357","article-title":"CMap analysis identifies Atractyloside as a potential drug candidate for type 2 diabetes based on integration of metabolomics and transcriptomics.","volume":"24","author":"Li","year":"2020","journal-title":"J. Cell Mol. Med."},{"key":"B54","doi-asserted-by":"publisher","first-page":"730","DOI":"10.1021\/acschemneuro.9b00610","article-title":"Zebrafish-based screening of antiseizure plants used in traditional chinese medicine: magnolia officinalis extract and its constituents magnolol and honokiol exhibit potent anticonvulsant activity in a therapy-resistant epilepsy model.","volume":"11","author":"Li","year":"2020","journal-title":"ACS Chem. Neurosci."},{"key":"B55","doi-asserted-by":"publisher","first-page":"923","DOI":"10.1093\/bioinformatics\/btt656","article-title":"featureCounts: an efficient general purpose program for assigning sequence reads to genomic features.","volume":"30","author":"Liao","year":"2014","journal-title":"Bioinformatics"},{"key":"B56","doi-asserted-by":"publisher","first-page":"1873","DOI":"10.1007\/s11064-017-2222-z","article-title":"Animal models of seizures and epilepsy: past, present, and future role for the discovery of antiseizure drugs.","volume":"42","author":"L\u00f6scher","year":"2017","journal-title":"Neurochem. Res."},{"key":"B57","doi-asserted-by":"publisher","first-page":"1055","DOI":"10.1007\/s40263-016-0384-x","article-title":"Synaptic vesicle glycoprotein 2A ligands in the treatment of epilepsy and beyond.","volume":"30","author":"Loscher","year":"2016","journal-title":"CNS Drugs"},{"key":"B58","doi-asserted-by":"publisher","DOI":"10.1186\/s13059-014-0550-8","article-title":"Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2.","volume":"15","author":"Love","year":"2014","journal-title":"Genome Biol."},{"key":"B59","doi-asserted-by":"publisher","first-page":"9861","DOI":"10.1073\/pnas.0308208101","article-title":"The synaptic vesicle protein SV2A is the binding site for the antiepileptic drug levetiracetam.","volume":"101","author":"Lynch","year":"2004","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"B60","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.nbd.2018.03.005","article-title":"Developmental excitatory-to-inhibitory GABA polarity switch is delayed in Ts65Dn mice, a genetic model of Down syndrome.","volume":"115","author":"Lysenko","year":"2018","journal-title":"Neurobiol. Dis."},{"key":"B61","doi-asserted-by":"publisher","first-page":"721","DOI":"10.1038\/nrd4627","article-title":"Zebrafish as tools for drug discovery.","volume":"14","author":"MacRae","year":"2015","journal-title":"Nat. Rev. Drug Discov."},{"key":"B62","doi-asserted-by":"publisher","first-page":"10","DOI":"10.14806\/ej.17.1.200","article-title":"Cutadapt removes adapter sequences from high-throughput sequencing reads.","volume":"17","author":"Martin","year":"2011","journal-title":"EMBnet J."},{"key":"B63","doi-asserted-by":"publisher","first-page":"1227","DOI":"10.1152\/jn.00279.2011","article-title":"A new mechanism for antiepileptic drug action: vesicular entry may mediate the effects of levetiracetam.","volume":"106","author":"Meehan","year":"2011","journal-title":"J. Neurophysiol."},{"key":"B64","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0166525","article-title":"Development and validation of a new mouse model to investigate the role of SV2A in epilepsy.","volume":"11","author":"Menten-Dedoyart","year":"2016","journal-title":"PLoS One"},{"key":"B65","doi-asserted-by":"publisher","first-page":"1242","DOI":"10.1111\/j.1460-9568.2012.08040.x","article-title":"Pharmacological mechanisms underlying switching from the large-scale depolarization wave to segregated activity in the mouse central nervous system.","volume":"35","author":"Momose-Sato","year":"2012","journal-title":"Eur. J. Neurosci."},{"key":"B66","doi-asserted-by":"publisher","first-page":"2607","DOI":"10.1093\/bioinformatics\/btp450","article-title":"ShortRead: a bioconductor package for input, quality assessment and exploration of high-throughput sequence data.","volume":"25","author":"Morgan","year":"2009","journal-title":"Bioinformatics"},{"key":"B67","doi-asserted-by":"publisher","first-page":"506","DOI":"10.1093\/bib\/bbw112","article-title":"A review of connectivity map and computational approaches in pharmacogenomics.","volume":"19","author":"Musa","year":"2018","journal-title":"Brief Bioinform."},{"key":"B68","doi-asserted-by":"publisher","DOI":"10.3390\/ijms222010962","article-title":"FosL1 is a novel target of levetiracetam for suppressing the microglial inflammatory reaction.","volume":"22","author":"Niidome","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"B69","doi-asserted-by":"publisher","first-page":"C960","DOI":"10.1152\/ajpcell.00259.2010","article-title":"SV2 regulates neurotransmitter release via multiple mechanisms.","volume":"299","author":"Nowack","year":"2010","journal-title":"Am. J. Physiol. Cell Physiol."},{"key":"B70","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2164-11-230","article-title":"Whole transcriptome analysis of the hippocampus: toward a molecular portrait of epileptogenesis.","volume":"11","author":"Okamoto","year":"2010","journal-title":"BMC Genomics"},{"key":"B71","doi-asserted-by":"publisher","DOI":"10.1523\/ENEURO.0055-21.2021","article-title":"Modeling neurodevelopmental disorders and epilepsy caused by loss of function of kif2a in Zebrafish.","volume":"8","author":"Partoens","year":"2021","journal-title":"eNeuro"},{"key":"B72","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1038\/s41573-021-00210-8","article-title":"Zebrafish disease models in drug discovery: from preclinical modelling to clinical trials.","volume":"20","author":"Patton","year":"2021","journal-title":"Nat. Rev. Drug Discov."},{"key":"B73","doi-asserted-by":"publisher","DOI":"10.1186\/s12868-016-0308-1","article-title":"mTOR and MAPK: from localized translation control to epilepsy.","volume":"17","author":"Pernice","year":"2016","journal-title":"BMC Neurosci."},{"key":"B74","doi-asserted-by":"publisher","DOI":"10.1101\/cshperspect.a022822","article-title":"Epileptogenesis.","volume":"5","author":"Pitkanen","year":"2015","journal-title":"Cold Spring Harb. Perspect. Med."},{"key":"B75","doi-asserted-by":"publisher","first-page":"3339","DOI":"10.4049\/jimmunol.167.6.3339","article-title":"Mycobacteria-induced TNF-alpha and IL-10 formation by human macrophages is differentially regulated at the level of mitogen-activated protein kinase activity.","volume":"167","author":"Reiling","year":"2001","journal-title":"J. Immunol."},{"key":"B76","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1016\/j.cbpa.2014.10.025","article-title":"15 years of zebrafish chemical screening.","volume":"24","author":"Rennekamp","year":"2015","journal-title":"Curr. Opin. Chem. Biol."},{"key":"B77","doi-asserted-by":"publisher","first-page":"2061","DOI":"10.1111\/epi.14576","article-title":"gamma-Aminobutyric acid receptor alpha 1 subunit loss of function causes genetic generalized epilepsy by impairing inhibitory network neurodevelopment.","volume":"59","author":"Samarut","year":"2018","journal-title":"Epilepsia"},{"key":"B78","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1016\/j.nbd.2017.09.004","article-title":"mTOR-related neuropathology in mutant tsc2 zebrafish: phenotypic, transcriptomic and pharmacological analysis.","volume":"108","author":"Scheldeman","year":"2017","journal-title":"Neurobiol. Dis."},{"key":"B79","doi-asserted-by":"publisher","first-page":"1327","DOI":"10.1038\/ng.3130","article-title":"Mutations in STX1B, encoding a presynaptic protein, cause fever-associated epilepsy syndromes.","volume":"46","author":"Schubert","year":"2014","journal-title":"Nat. Genet."},{"key":"B80","doi-asserted-by":"publisher","first-page":"2011","DOI":"10.1158\/1078-0432.CCR-19-2884","article-title":"Gene expression signatures identify novel therapeutics for metastatic pancreatic neuroendocrine tumors.","volume":"26","author":"Scott","year":"2020","journal-title":"Clin. Cancer Res."},{"key":"B81","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1093\/glycob\/cwu015","article-title":"The role of protein N-glycosylation in neural transmission.","volume":"24","author":"Scott","year":"2014","journal-title":"Glycobiology"},{"key":"B82","doi-asserted-by":"publisher","first-page":"642","DOI":"10.1016\/j.pediatrneurol.2015.02.011","article-title":"Homozygous mutation in synaptic vesicle glycoprotein 2A gene results in intractable epilepsy, involuntary movements, microcephaly, and developmental and growth retardation.","volume":"52","author":"Serajee","year":"2015","journal-title":"Pediatr. Neurol."},{"key":"B83","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-018-07953-w","article-title":"Biallelic VARS variants cause developmental encephalopathy with microcephaly that is recapitulated in vars knockout zebrafish.","volume":"10","author":"Siekierska","year":"2019","journal-title":"Nat. Commun."},{"key":"B84","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1111\/j.1535-7511.2009.01351.x","article-title":"SV2A in epilepsy: the plot thickens.","volume":"10","author":"Sills","year":"2010","journal-title":"Epilepsy Curr."},{"key":"B85","doi-asserted-by":"publisher","first-page":"837","DOI":"10.1016\/j.ncl.2016.06.015","article-title":"The epidemiology of global epilepsy.","volume":"34","author":"Singh","year":"2016","journal-title":"Neurol. Clin."},{"key":"B86","doi-asserted-by":"publisher","first-page":"1620","DOI":"10.1016\/j.febslet.2015.05.004","article-title":"Changing channels in pain and epilepsy: exploiting ion channel gene therapy for disorders of neuronal hyperexcitability.","volume":"589","author":"Snowball","year":"2015","journal-title":"FEBS Lett."},{"key":"B87","doi-asserted-by":"publisher","DOI":"10.1101\/cshperspect.a022426","article-title":"Seizures and epilepsy: an overview for neuroscientists.","volume":"5","author":"Stafstrom","year":"2015","journal-title":"Cold Spring Harb. Perspect. Med."},{"key":"B88","doi-asserted-by":"publisher","DOI":"10.1177\/1756286419873518","article-title":"Levetiracetam and brivaracetam: a review of evidence from clinical trials and clinical experience.","volume":"12","author":"Steinhoff","year":"2019","journal-title":"Ther. Adv. Neurol. Disord."},{"key":"B89","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1007\/s00441-014-1849-1","article-title":"Calcium signaling and epilepsy.","volume":"357","author":"Steinlein","year":"2014","journal-title":"Cell Tissue Res."},{"key":"B90","doi-asserted-by":"publisher","DOI":"10.1016\/j.cub.2018.04.061","article-title":"Non-canonical mTOR-independent Role of DEPDC5 in Regulating GABAergic network development.","volume":"28","author":"Swaminathan","year":"2018","journal-title":"Curr. Biol."},{"key":"B91","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1016\/j.neuroscience.2016.11.017","article-title":"Molecular neurobiology of mTOR.","volume":"341","author":"Switon","year":"2017","journal-title":"Neuroscience"},{"key":"B92","doi-asserted-by":"publisher","first-page":"1409","DOI":"10.1111\/j.1528-1167.2008.01955.x","article-title":"Expression patterns of synaptic vesicle protein 2A in focal cortical dysplasia and TSC-cortical tubers.","volume":"50","author":"Toering","year":"2009","journal-title":"Epilepsia"},{"key":"B93","doi-asserted-by":"publisher","DOI":"10.1038\/srep27420","article-title":"Synaptic vesicle glycoprotein 2A (SV2A) regulates kindling epileptogenesis via GABAergic neurotransmission.","volume":"6","author":"Tokudome","year":"2016","journal-title":"Sci. Rep."},{"key":"B94","doi-asserted-by":"publisher","DOI":"10.3389\/fncel.2013.00020","article-title":"Excitatory actions of GABA in the intact neonatal rodent hippocampus in vitro.","volume":"7","author":"Valeeva","year":"2013","journal-title":"Front. Cell. Neurosci."},{"key":"B95","doi-asserted-by":"publisher","first-page":"422","DOI":"10.1111\/j.1528-1167.2008.01727.x","article-title":"Decreased expression of synaptic vesicle protein 2A, the binding site for levetiracetam, during epileptogenesis and chronic epilepsy.","volume":"50","author":"van Vliet","year":"2009","journal-title":"Epilepsia"},{"key":"B96","doi-asserted-by":"publisher","first-page":"1626","DOI":"10.1038\/nm.2982","article-title":"Before epilepsy unfolds: finding the epileptogenesis switch.","volume":"18","author":"Vezzani","year":"2012","journal-title":"Nat. Med."},{"key":"B97","doi-asserted-by":"publisher","first-page":"234","DOI":"10.20517\/2347-8659.2020.02","article-title":"Microglial contributions to aberrant neurogenesis and pathophysiology of epilepsy.","volume":"7","author":"Victor","year":"2020","journal-title":"Neuroimmunol. Neuroinflamm."},{"key":"B98","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1124\/mol.111.076687","article-title":"The synaptic vesicle glycoprotein 2A ligand levetiracetam inhibits presynaptic Ca2+ channels through an intracellular pathway.","volume":"82","author":"Vogl","year":"2012","journal-title":"Mol. Pharmacol."},{"key":"B99","doi-asserted-by":"publisher","first-page":"1345","DOI":"10.1001\/jamaneurol.2021.3310","article-title":"Effect of levetiracetam on cognition in patients with alzheimer disease with and without epileptiform activity: a randomized clinical trial.","volume":"78","author":"Vossel","year":"2021","journal-title":"JAMA Neurol."},{"key":"B100","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1016\/j.clineuro.2019.03.020","article-title":"Levetiracetam-induced a new seizure type in a girl with a novel SV2A gene mutation.","volume":"181","author":"Wang","year":"2019","journal-title":"Clin. Neurol. Neurosurg."},{"key":"B101","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0020763","article-title":"A systems level, functional genomics analysis of chronic epilepsy.","volume":"6","author":"Winden","year":"2011","journal-title":"PLoS One"},{"key":"B102","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1124\/jpet.119.261149","article-title":"Pharmacological profile of the novel antiepileptic drug candidate padsevonil: interactions with synaptic vesicle 2 proteins and the GABAA receptor.","volume":"372","author":"Wood","year":"2020","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"B103","doi-asserted-by":"publisher","first-page":"691","DOI":"10.1038\/35087000","article-title":"SV2 modulates the size of the readily releasable pool of secretory vesicles.","volume":"3","author":"Xu","year":"2001","journal-title":"Nat. Cell Biol."},{"key":"B104","doi-asserted-by":"publisher","first-page":"7243","DOI":"10.1111\/febs.15694","article-title":"Past, present and future of zebrafish in epilepsy research.","volume":"288","author":"Yaksi","year":"2021","journal-title":"FEBS J."},{"key":"B105","doi-asserted-by":"publisher","first-page":"5569","DOI":"10.1523\/JNEUROSCI.4781-09.2010","article-title":"Cotrafficking of SV2 and synaptotagmin at the synapse.","volume":"30","author":"Yao","year":"2010","journal-title":"J. Neurosci."},{"key":"B106","doi-asserted-by":"publisher","first-page":"1312","DOI":"10.1016\/j.leukres.2015.10.010","article-title":"Clinical activity of alvocidib (flavopiridol) in acute myeloid leukemia.","volume":"39","author":"Zeidner","year":"2015","journal-title":"Leuk. Res."},{"key":"B107","doi-asserted-by":"publisher","first-page":"2557","DOI":"10.1113\/jphysiol.2010.187088","article-title":"Development of light response and GABAergic excitation-to-inhibition switch in zebrafish retinal ganglion cells.","volume":"588","author":"Zhang","year":"2010","journal-title":"J. Physiol."},{"key":"B108","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-017-06294-w","article-title":"Inhibition of glutamate decarboxylase (GAD) by ethyl ketopentenoate (EKP) induces treatment-resistant epileptic seizures in zebrafish.","volume":"7","author":"Zhang","year":"2017","journal-title":"Sci. Rep."}],"container-title":["Frontiers in Molecular Neuroscience"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fnmol.2022.881933\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,5,24]],"date-time":"2022-05-24T16:25:26Z","timestamp":1653409526000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fnmol.2022.881933\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,5,24]]},"references-count":108,"alternative-id":["10.3389\/fnmol.2022.881933"],"URL":"https:\/\/doi.org\/10.3389\/fnmol.2022.881933","relation":{},"ISSN":["1662-5099"],"issn-type":[{"value":"1662-5099","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,5,24]]},"article-number":"881933"}}